MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric Cancer

Table 1

The clinical characteristics of study subjects.

GC^a	Gender	Age (year)	Differentiation	AJCC^b stage
GC01	Male	76	Poor	III
GC02	Female	59	Poor	I
GC03	Male	60	Moderate/poor	III
GC04	Male	48	Poor	III
GC05	Male	77	Moderate	II
GC06	Female	69	Poor/mucinous	III
GC07	Male	49	Poor/mucinous	III
GC08	Female	58	Moderate/poor	II
GC09	Male	54	Poor	I
GC10	Female	70	Moderate/poor	III
GC11	Male	52	Moderate	II
GC12	Male	57	Poor/mucinous	III
GC13	Female	52	Poor/mucinous	II
GC14	Male	70	Moderate/poor	II
GC15	Male	65	Moderate/poor	III
GC16	Male	58	Poor	II
GC17	Male	58	Moderate/poor	II
GC18	Female	71	Poor	III
GC19	Female	55	Poor	III
GC20	Female	58	Poor	III
GC21	Female	64	Poor	III
GC22	Male	71	Moderate	I
GC23	Male	50	Poor/mucinous	III
GC24	Female	76	Moderate/poor	III
GC25	Female	55	Moderate	I

GC: gastric cancer; ^bAJCC: the American Joint Committee on Cancer.